Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug

AI SUMMARY

# Moderna's Bob Langer and AI Pioneer Yann LeCun Join Cellular Intelligence Board Cellular Intelligence has recruited high-profile AI and biotech talent—including Moderna's Bob Langer and Yann LeCun (AI pioneer)—to its board while adding OpenAI's Fidji Simo in an advisory role, positioning itself to leverage machine learning for drug development as it evaluates models on Novo Nordisk's Parkinson's treatment. This move signals potential competitive pressure on traditional biotech players like Novo Nord